ADMA Biologics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2830 www.admabiologics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics, Inc.

Mizuho Cuts PT on ADMA Biologics Inc. (ADMA) to $24 From $30 - Apr 19th, 2026 6:12 pm
Cantor Fitzgerald Downgrades ADMA Biologics Inc. (ADMA) to Neutral From Overweight - Apr 19th, 2026 6:09 pm
NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program - Apr 17th, 2026 8:28 am
Is It Time To Reassess ADMA Biologics (ADMA) After Recent Share Price Volatility - Apr 17th, 2026 6:07 am
Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns? - Apr 16th, 2026 10:54 am
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - Apr 16th, 2026 7:55 am
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Apr 15th, 2026 3:50 pm
ADMA Crashes 42.5% YTD: Right Time to Buy the Stock? - Apr 15th, 2026 12:58 pm
TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication - Apr 15th, 2026 8:37 am
NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up - Apr 15th, 2026 8:17 am
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes - Apr 13th, 2026 9:31 am
Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral, Here’s Why - Apr 12th, 2026 12:31 pm
Is ADMA Poised for Margin Growth and Supply Expansion in 2026? - Apr 10th, 2026 8:00 am
Adma Biologics (ADMA) Laps the Stock Market: Here's Why - Apr 9th, 2026 3:50 pm
US High Growth Tech Stocks To Watch For Potential Expansion - Apr 3rd, 2026 11:38 am
Janux Therapeutics Secures $35M Milestone Payment From BMY Deal - Apr 2nd, 2026 12:29 pm
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026? - Apr 1st, 2026 8:23 am
NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up - Apr 1st, 2026 8:11 am
Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio - Apr 1st, 2026 8:07 am
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Mar 31st, 2026 3:45 pm